Trial Profile
A study on the safety and effectiveness of tolvaptan for patients with fluid retention after valvular surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Cardiac oedema
- Focus Therapeutic Use
- 29 Sep 2015 Status changed from not yet recruiting to completed, as reported by University Hospital Medical Information Network - Japan.
- 11 Feb 2013 New trial record